Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
Explore more from The Transmitter
Autism in Kenya, organoid research, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 December.
Autism in Kenya, organoid research, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 December.
‘Unprecedented’ dorsal root ganglion atlas captures 22 types of human sensory neurons
The atlas also offers up molecular and cellular targets for new pain therapies.
‘Unprecedented’ dorsal root ganglion atlas captures 22 types of human sensory neurons
The atlas also offers up molecular and cellular targets for new pain therapies.
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.